Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-21-006164

CEO acquired 212,500 shares (option exercise)

  • CEO acquired 24,038 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2021-03-12 Option exercise +25,000 $0.61 $15,125 635,500 I: show line 1 in the form
Woods Lori A CEO 2021-03-12 Option exercise +62,500 $0.46 $28,750 698,000 I: show line 2 in the form
Woods Lori A CEO 2021-03-12 Option exercise +62,500 $0.43 $26,875 760,500 I: show line 3 in the form
Woods Lori A CEO 2021-03-12 Option exercise +62,500 $0.61 $38,125 823,000 I: show line 4 in the form
Woods Lori A CEO 2021-03-12 Option exercise +24,038 $0.57 $13,702 847,038 I: show line 5 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Woods Lori A CEO 2021-03-12 Option exercise · Stock Options (right to buy) −25,000 0 D: show line 6 in the form
Woods Lori A CEO 2021-03-12 Option exercise · Stock Options (right to buy) −62,500 62,500 D: show line 7 in the form
Woods Lori A CEO 2021-03-12 Option exercise · Stock Options (right to buy) −62,500 125,000 D: show line 8 in the form
Woods Lori A CEO 2021-03-12 Option exercise · Stock Options (right to buy) −62,500 187,500 D: show line 9 in the form
Woods Lori A CEO 2021-03-12 Option exercise · Warrant (right to buy) −24,038 0 D: show line 10 in the form
Loading xslF345X03/rdgdoc.xml…